Detalhe da pesquisa
1.
Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?
Int J Mol Sci
; 24(16)2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37628803
2.
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Lancet Oncol
; 23(4): 540-552, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358455
3.
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer.
Int J Mol Sci
; 23(15)2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955721
4.
COVID and Lung Cancer.
Curr Oncol Rep
; 23(11): 134, 2021 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34677721
5.
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.
Int J Cancer
; 145(8): 2238-2248, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018250
6.
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.
Oncologist
; 24(11): e1165-e1171, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996007
7.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262187
8.
Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge.
Cancer Immunol Immunother
; 67(8): 1317-1324, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943157
9.
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Tumour Biol
; 40(11): 1010428318815047, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30486741
10.
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Oncol
; 18(9): 1261-1273, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729154
11.
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?
Cancer Immunol Immunother
; 64(1): 105-12, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25233793
12.
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
Cancer Immunol Immunother
; 69(6): 1141-1151, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025818
13.
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 14(11): 1104-1111, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24035405
14.
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial.
Eur J Cancer
; 199: 113531, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271746
15.
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
Cancer Immunol Immunother
; 62(6): 1021-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591982
16.
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
J Transl Med
; 11: 137, 2013 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23731854
17.
The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysis.
Clin Exp Med
; 23(5): 1551-1561, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401744
18.
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.
J Clin Med
; 12(24)2023 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137806
19.
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.
Front Immunol
; 14: 1333661, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38259475
20.
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
Cancer Immunol Immunother
; 61(1): 41-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21833591